This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Mania Induced by Risperidone: Dose Related?

HsienYuan Lane, YuiChing Lin, and WenHo Chang

Published: February 15, 1998

Article Abstract

Sir: Risperidone is a serotonin-2/dopamine-2 (5-HT2/D2) receptor antagonist that has demonstrated efficacy in the treatment of schizophrenia. It has also been suggested to possess acute antimanic effects in some patients. Other preliminary data, however, indicate that risperidone may initiate or exacerbate manic symptoms owing to its putative antidepressant activity.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...